Drug Type Biological products |
Synonyms Ancer20, SSM, 结核杆菌热水提取物 + [2] |
Target- |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (26 Aug 1991), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Leukopenia | JP | 26 Aug 1991 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Locally Advanced Cervical Carcinoma | Phase 3 | JP | 01 Dec 2014 | |
Locally Advanced Cervical Carcinoma | Phase 3 | MY | 01 Dec 2014 | |
Locally Advanced Cervical Carcinoma | Phase 3 | SG | 01 Dec 2014 | |
Locally Advanced Cervical Carcinoma | Phase 3 | KR | 01 Dec 2014 | |
Locally Advanced Cervical Carcinoma | Phase 3 | TW | 01 Dec 2014 | |
Locally Advanced Cervical Carcinoma | Phase 3 | TH | 01 Dec 2014 | |
Locally Advanced Cervical Carcinoma | Phase 3 | VN | 01 Dec 2014 | |
HIV Infections | Phase 1 | US | 31 Aug 2001 |
Phase 3 | 249 | bbsywcobzm(lbsyzwqbxm) = wvvyhrrina ohcnyrxjfi (tbxvdmlmgr, 66.4 - 82.8) | Positive | 20 May 2013 | |||
Placebo | bbsywcobzm(lbsyzwqbxm) = wusmibjwlk ohcnyrxjfi (tbxvdmlmgr, 56.2 - 73.8) |